SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000908834-23-000114
Filing Date
2023-09-22
Accepted
2023-09-22 15:20:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 beam13g.htm SC 13G 607252
  Complete submission text file 0000908834-23-000114.txt   608928
Mailing Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111
Business Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111 (415) 421-2132
Farallon Capital Partners, L.P. (Filed by) CIK: 0001175707 (see all company filings)

IRS No.: 943106322 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Subject) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91369 | Film No.: 231271451
SIC: 2836 Biological Products, (No Diagnostic Substances)